Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for KPI-121 0.25% for Dry Eye Disease October 16, 2018 08:00 AM Eastern Daylight Time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results